CS
EDIT icon

Credit Suisse’s Editas Medicine EDIT Stock Holding History

Credit Suisse’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,000
Closed -$41K – 4539
2021
Q3 		$41K Sell
1,000
-8,500
-89% -$466K ﹤0.01% 4353
2021
Q2 		$538K Sell
9,500
-41,200
-81% -$1.52M ﹤0.01% 3797
2021
Q1 		$2.13M Buy
+50,700
New +$2.89M ﹤0.01% 2770

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Credit Suisse's EDIT Position: Q1 2024 in Review

Credit Suisse increased its Editas Medicine (EDIT) stake by 0.76% in Q1 2024, buying an estimated $56.3K and bringing the position to 903,257 shares worth $6.7M. The position accounts for 0.01% of the portfolio, ranked #1139.

Credit Suisse first reported a position in EDIT in Q3 2016 and has held it in 31 quarters since. The position peaked at $59.5M in Q4 2020. 225 funds tracked by Wall St. Rank hold EDIT as of Q1 2024.

  • Credit Suisse held 903,257 shares of Editas Medicine worth $6.7M as of Q1 2024.
  • Credit Suisse bought 6,781 Editas Medicine shares in Q1 2024, an estimated $56.3K.
  • Editas Medicine made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #1139 holding.
  • Credit Suisse first reported a position in Editas Medicine in Q3 2016 and has held it in 31 quarters since.
  • Credit Suisse's Editas Medicine position peaked at $59.5M in Q4 2020.
  • 225 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.